Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease characterized primarily by the formation of heterotopic bone in connective tissue, such as tendon, muscle, ligament and fascia (Kaplan et al, 2024). The prevalence is approximately one in 2.5 million births, with over 2,500 cases...
Saved in:
| Main Authors: | Qiwen Li, Quan Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2024-12-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.1038/s44321-024-00180-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-β signaling
by: Chengzhu Zhao, et al.
Published: (2024-12-01) -
The Fibrodysplasia Ossificans Progressiva and Bone Scintigraphy
by: Sofia CHKIKAR, et al.
Published: (2024-04-01) -
Fibrodysplasia ossificans progressiva: case report
by: ANAMARLI NUCCI, et al.
Published: (2000-06-01) -
Fibrodysplasia ossificans progressiva: a case report
by: Merih Önal, et al.
Published: (2014-10-01) -
Respiratory oscillometry in individuals with fibrodysplasia ossificans progressiva
by: Anastasiia Vasileva, et al.
Published: (2025-07-01)